Literature DB >> 10520140

Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones.

G Okugawa1, K Omori, J Suzukawa, Y Fujiseki, T Kinoshita, C Inagaki.   

Abstract

Since the glucocorticoid receptor (GR) and/or mineralocorticoid receptor (MR) in the hippocampus have been implicated in cortisol feedback of the hypothalamus-pituitary-adrenal (HPA) axis, abnormalities in those receptors might underlie the hyperactivity of the HPA axis described in patients with major depression. Animal studies have shown that long-term in-vivo treatment with antidepressants up-regulates hippocampal GR and/or MR, but it is not clear whether this up-regulation is evoked through a direct action of antidepressants on these receptors. We therefore examined the direct effects of long-term antidepressant treatment on GR binding and the levels of GR messenger RNA (mRNA) in primary cultures of rat hippocampal neurones. The time course of the effects of the tricyclic antidepressants desipramine and amitriptyline on GR binding, as assessed by [3H]dexamethasone binding using RU 28362, a specific agonist for GR, showed a biphasic mode of stimulation: desipramine significantly increased the GR binding with 2-day exposure by 36% over that in controls and by 99% and 60% with 10- and 14-day exposures, respectively. Amitriptyline also led to a significant increase in GR binding, with peaks at 2 (by 60%) and 14 days of exposure (by 60%). The effects of 14-day treatment with desipramine required at least the first 4-day exposure, and the first 10-day exposure was required for the full effect. Northern blot analysis demonstrated that the GR mRNA level was significantly increased by 14-day treatment with desipramine (+142% over control), amitriptyline (+108%), mianserin (+124%), paroxetine (+42%) and sulpiride (+92%), but not with haloperidol. Immunocytochemistry for GR revealed that 2- or 14-day treatment with desipramine significantly increased the number of GR-positive cells with dominant immunoreactivity in the nuclei of granule cell-like neurones or in perikarya of pyramidal cell- and granule cell-like neurones. These findings suggest that tricyclic antidepressants directly increase hippocampal GR by short-term (2-day) and long-term (14-day) exposure, and that the increase by long-term exposure is evoked commonly with different classes of antidepressants through transcriptional up-regulation of GR expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10520140     DOI: 10.1046/j.1365-2826.1999.00405.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  17 in total

1.  Coping and glucocorticoid receptor regulation by stress inoculation.

Authors:  Alex G Lee; Christine L Buckmaster; Esther Yi; Alan F Schatzberg; David M Lyons
Journal:  Psychoneuroendocrinology       Date:  2014-08-01       Impact factor: 4.905

2.  A mixed glucocorticoid/mineralocorticoid receptor modulator dampens endocrine and hippocampal stress responsivity in male rats.

Authors:  Elizabeth T Nguyen; Joshua Streicher; Sarah Berman; Jody L Caldwell; Valentina Ghisays; Christina M Estrada; Aynara C Wulsin; Matia B Solomon
Journal:  Physiol Behav       Date:  2017-01-14

3.  Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription - a possible mechanism.

Authors:  B Budziszewska; L Jaworska-Feil; M Kajta; W Lasoń
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

Review 4.  The glucocorticoid receptor: pivot of depression and of antidepressant treatment?

Authors:  Christoph Anacker; Patricia A Zunszain; Livia A Carvalho; Carmine M Pariante
Journal:  Psychoneuroendocrinology       Date:  2011-04       Impact factor: 4.905

5.  Identification of molecules potentially involved in mediating the in vivo actions of the corticotropin-releasing hormone receptor 1 antagonist, NBI30775 (R121919).

Authors:  Anke Post; Frauke Ohl; Osborne F X Almeida; Elisabeth B Binder; Monika Rücker; Sandra Welt; Elke Binder; Florian Holsboer; Inge Sillaber
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

6.  Analysis of region-specific changes in gene expression upon treatment with citalopram and desipramine reveals temporal dynamics in response to antidepressant drugs at the transcriptome level.

Authors:  Magdalena Gąska; Maciej Kuśmider; Joanna Solich; Agata Faron-Górecka; Małgorzata J Krawczyk; Krzysztof Kułakowski; Marta Dziedzicka-Wasylewska
Journal:  Psychopharmacology (Berl)       Date:  2012-05-01       Impact factor: 4.530

7.  Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.

Authors:  Georg Nikisch; Aleksander A Mathé; Adelheid Czernik; Jutta Thiele; Jürgen Bohner; Chin B Eap; Hans Agren; Pierre Baumann
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

Review 8.  Lithium: a versatile tool for understanding renal physiology.

Authors:  Bellamkonda K Kishore; Carolyn M Ecelbarger
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-13

9.  Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala.

Authors:  Elizabeth I Flandreau; Chase H Bourke; Kerry J Ressler; Wylie W Vale; Charles B Nemeroff; Michael J Owens
Journal:  Psychoneuroendocrinology       Date:  2012-12-23       Impact factor: 4.905

10.  The selective glucocorticoid receptor antagonist CORT 108297 decreases neuroendocrine stress responses and immobility in the forced swim test.

Authors:  Matia B Solomon; Aynara C Wulsin; Taylor Rice; Dayna Wick; Brent Myers; Jessica McKlveen; Jonathan N Flak; Yvonne Ulrich-Lai; James P Herman
Journal:  Horm Behav       Date:  2014-02-11       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.